AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇦

Diphenhydramine Hydrochloride in South Africa

9 products registered with SAHPRA 5 active

Brand / ProductReg. No.HolderStatusExpires
BENYLIN FORTE56/10.1/0570Johnson & Johnson (Pty) Ltd û Cape Townactive8 Oct 2029
MYPAID NIGHT PAIN36/2.9/0199Adcock Ingram Limitedsuspended17 Jun 2025
PROCOFQ/10.1/243ACINO PHARMA (PTY) LTDsuspended31 Oct 2023
BENNET'S DIPHENHYDRAMINE ELIXIR*28/5.7/0483HERSOL MANUFACTURING LABORATORIES CCsuspended16 Aug 2023
FOLCOFENN/10.1/99Ascendis Pharma (Pty) Ltdsuspended4 Apr 2023
BENYLIN FOUR FLU TABLETS33/5.8/0509Johnson & Johnson (Pty) Ltd û East Londonactive1 Jan 1900
BENYLIN FOUR FLU LIQUID33/5.8/0345Johnson & Johnson (Pty) Ltd û East Londonactive1 Jan 1900
SLEEPEZE-PM TABLETSN/2.2/37GlaxoSmithKline Consumer Healthcare SA (Pty) Ltdactive1 Jan 1900
BENYLIN PAEDIATRICH/1001/12Johnson & Johnson (Pty) Ltd û East Londonactive1 Jan 1900

Diphenhydramine HydrochlorideSAHPRA Registration Details

SAHPRA (South Africa) has 9 registered products containing Diphenhydramine Hydrochloride, of which 5 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Diphenhydramine Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.